These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29116020)

  • 1. Assessment of safety and efficacy of mesenchymal stromal cell therapy in preclinical models of acute myocardial infarction: a systematic review protocol.
    Barron CC; Lalu MM; Stewart DJ; Fergusson D; Yang H; Moher D; Liu P; Mazer D; Devereaux PJ; McIntyre L;
    Syst Rev; 2017 Nov; 6(1):226. PubMed ID: 29116020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol.
    Lalu MM; Moher D; Marshall J; Fergusson D; Mei SH; Macleod M; Griffin G; Turgeon AF; Rudnicki M; Fishman J; Avey MT; Skidmore B; Grimshaw JM; Stewart DJ; Singh K; McIntyre L;
    Syst Rev; 2014 May; 3():48. PubMed ID: 24887266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactive scaffolds in stem-cell-based therapies for cardiac repair: protocol for a meta-analysis of randomized controlled preclinical trials in animal myocardial infarction models.
    Khan K; Gasbarrino K; Mahmoud I; Makhoul G; Yu B; Dufresne L; Daskalopoulou SS; Schwertani A; Cecere R
    Syst Rev; 2018 Dec; 7(1):225. PubMed ID: 30518435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational transplant timing and dose of mesenchymal stromal cells in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Wang Z; Wang L; Su X; Pu J; Jiang M; He B
    Stem Cell Res Ther; 2017 Jan; 8(1):21. PubMed ID: 28129790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary Transplantation of Mesenchymal Stem Cells with Overexpressed Integrin-Linked Kinase Improves Cardiac Function in Porcine Myocardial Infarction.
    Mu D; Zhang XL; Xie J; Yuan HH; Wang K; Huang W; Li GN; Lu JR; Mao LJ; Wang L; Cheng L; Mai XL; Yang J; Tian CS; Kang LN; Gu R; Zhu B; Xu B
    Sci Rep; 2016 Jan; 6():19155. PubMed ID: 26750752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental benefits of repeated mesenchymal stromal cell administration compared with solitary intervention after myocardial infarction.
    Richardson JD; Psaltis PJ; Frost L; Paton S; Carbone A; Bertaso AG; Nelson AJ; Wong DT; Worthley MI; Gronthos S; Zannettino AC; Worthley SG
    Cytotherapy; 2014 Apr; 16(4):460-70. PubMed ID: 24113430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of mesenchymal stem cells overexpressing IL10 attenuates cardiac impairments in rats with myocardial infarction.
    Meng X; Li J; Yu M; Yang J; Zheng M; Zhang J; Sun C; Liang H; Liu L
    J Cell Physiol; 2018 Jan; 233(1):587-595. PubMed ID: 28322445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of freshly cultured versus freshly thawed (cryopreserved) mesenchymal stem cells in preclinical in vivo models of inflammation: a protocol for a preclinical systematic review and meta-analysis.
    Dave C; McRae A; Doxtator E; Mei SHJ; Sullivan K; Wolfe D; Champagne J; McIntyre L
    Syst Rev; 2020 Aug; 9(1):188. PubMed ID: 32814560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Umbilical Cord-Derived Mesenchymal Stromal Cells Improve Left Ventricular Function, Perfusion, and Remodeling in a Porcine Model of Chronic Myocardial Ischemia.
    Liu CB; Huang H; Sun P; Ma SZ; Liu AH; Xue J; Fu JH; Liang YQ; Liu B; Wu DY; Lü SH; Zhang XZ
    Stem Cells Transl Med; 2016 Aug; 5(8):1004-13. PubMed ID: 27334487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of regenerative cell therapy for pulmonary arterial hypertension in animal models: a preclinical systematic review protocol.
    Suen CM; Zhai A; Lalu MM; Welsh C; Levac BM; Fergusson D; McIntyre L; Stewart DJ
    Syst Rev; 2016 May; 5():89. PubMed ID: 27225668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Adult Stem Cell Therapy for Acute Myocardial Infarction and Ischemic Heart Failure (SafeCell Heart): A Systematic Review and Meta-Analysis.
    Lalu MM; Mazzarello S; Zlepnig J; Dong YYR; Montroy J; McIntyre L; Devereaux PJ; Stewart DJ; David Mazer C; Barron CC; McIsaac DI; Fergusson DA
    Stem Cells Transl Med; 2018 Dec; 7(12):857-866. PubMed ID: 30255989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells for sensorineural hearing loss: protocol for a systematic review of preclinical studies.
    Chorath KT; Willis MJ; Morton-Gonzaba N; Humann WJ; Moreira A
    Syst Rev; 2019 May; 8(1):126. PubMed ID: 31128597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin treatment improves effects of implanted mesenchymal stem cells: meta-analysis of animal models with acute myocardial infarction.
    Dai G; Xu Q; Luo R; Gao J; Chen H; Deng Y; Li Y; Wang Y; Yuan W; Wu X
    BMC Cardiovasc Disord; 2015 Dec; 15():170. PubMed ID: 26667804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracardiac-Lodged Mesenchymal Stromal Cells Propel an Inflammatory Response Against Myocardial Infarction via Paracrine Effects.
    Peng Y; Pan W; Ou Y; Xu W; Kaelber S; Borlongan CV; Sun M; Yu G
    Cell Transplant; 2016; 25(5):929-35. PubMed ID: 26498018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Safety and Efficacy of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Patients With Heart Failure and Myocardial Infarction: A Meta-Analysis of Clinical Trials.
    Abouzid MR; Ali K; Kamel I; Esteghamati S; Saleh A; Ghanim M
    Cureus; 2023 Nov; 15(11):e49645. PubMed ID: 38033439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of magnetically labeled mesenchymal stem cells improves cardiac function in a swine myocardial infarction model.
    Qi CM; Ma GS; Liu NF; Shen CX; Chen Z; Liu XJ; Hu YP; Zhang XL; Teng GJ; Ju SH; Ma M; Tang YL
    Chin Med J (Engl); 2008 Mar; 121(6):544-50. PubMed ID: 18364144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart.
    Dakhlallah D; Zhang J; Yu L; Marsh CB; Angelos MG; Khan M
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):241-51. PubMed ID: 25658461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods and efficacy of extracellular vesicles derived from mesenchymal stromal cells in animal models of disease: a preclinical systematic review protocol.
    Tieu A; Slobodian M; Fergusson DA; Montroy J; Burger D; Stewart DJ; Shorr R; Allan DS; Lalu MM
    Syst Rev; 2019 Dec; 8(1):322. PubMed ID: 31831057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal Stem Cell Exosomes in the Treatment of Myocardial Infarction: a Systematic Review of Preclinical In Vivo Studies.
    Meng H; Cheng W; Wang L; Chen S; Teng Y; Lu Z; Li Y; Zhao M
    J Cardiovasc Transl Res; 2022 Apr; 15(2):317-339. PubMed ID: 34611844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction.
    Liu C; Fan Y; Zhou L; Zhu HY; Song YC; Hu L; Wang Y; Li QP
    Int J Cardiol; 2015 Jun; 188():22-32. PubMed ID: 25880576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.